Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
Open Forum Infectious Diseases|January 24, 2022
Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After InfectionKei Miyakawa, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, et al.
Frontiers in Microbiology|May 24, 2021
Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 SurvivorsAtsushi Goto, Hirofumi Go, Kei Miyakawa, et al.
Cell Reports|December 16, 2023
Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivoRyuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, et al.
Microbial Genomics|July 7, 2026
Genomic analysis of intrahospital transmission of carbapenem-resistant Gram-negative bacteria: a multicentre study in JapanYasufumi Matsumura, Yohei Doi, Kayoko Hayakawa, et al.
Microbiology Spectrum|April 27, 2026
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in JapanKoji Ohyama, Kohei Uemura, Yasufumi Matsumura, et al.
Japanese Journal of Radiology|April 9, 2022
Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effectYoshiharu Ohno, Kota Aoyagi, Kazumasa Arakita, et al.
Open Forum Infectious Diseases|October 17, 2025
Features of Carbapenem-resistant Gram-negative Bacterial Infections in Japan Based on the Setting of OnsetYuya Kawamoto, Yusuke Asai, Aki Sakurai, et al.
Influenza and Other Respiratory Viruses|April 26, 2022
Behavioral factors associated with SARS-CoV-2 infection in JapanTakeshi Arashiro, Yuzo Arima, Hirokazu Muraoka, et al.
Plos One|January 11, 2021
The psychological effects of COVID-19 on hospital workers at the beginning of the outbreak with a large disease cluster on the Diamond Princess cruise shipKeiko Ide, Takeshi Asami, Akira Suda, et al.
HLA|July 23, 2024
HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumoniaKatsushi Tanaka, Akira Meguro, Yu Hara, et al.
Pageof 22